Equities

Phytohealth Corp

4108:TAI

Phytohealth Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)18.05
  • Today's Change0.00 / 0.00%
  • Shares traded175.52k
  • 1 Year change-9.98%
  • Beta--
Data delayed at least 20 minutes, as of Sep 23 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,2661,3611,415
Total Receivables, Net362620
Total Inventory163151146
Prepaid expenses333037
Other current assets, total0.800.510.77
Total current assets1,4991,5681,618
Property, plant & equipment, net246275307
Goodwill, net313131
Intangibles, net435159
Long term investments527434450
Note receivable - long term------
Other long term assets3.825.244.83
Total assets2,3512,3652,470
LIABILITIES
Accounts payable2.505.791.99
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases119.9611
Other current liabilities, total444644
Total current liabilities576256
Total long term debt172020
Total debt283031
Deferred income tax------
Minority interest344370408
Other liabilities, total5.015.015.00
Total liabilities423457489
SHAREHOLDERS EQUITY
Common stock1,9861,9861,986
Additional paid-in capital1.160.52357
Retained earnings (accumulated deficit)(191)(157)(441)
Treasury stock - common------
Unrealized gain (loss)1317879
Other equity, total------
Total equity1,9271,9081,981
Total liabilities & shareholders' equity2,3512,3652,470
Total common shares outstanding199199197
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.